In the BioHarmony Drug Report Database
Triamcinolone hexacetonide
Aristospan (triamcinolone hexacetonide) is a small molecule pharmaceutical. Triamcinolone hexacetonide was first approved as Aristospan on 1982-01-01. It is used to treat adrenal insufficiency, allergic rhinitis perennial, ankylosing spondylitis, atopic dermatitis, and berylliosis amongst others in the USA.
Trade Name
|
Aristospan |
|---|---|
Common Name
|
triamcinolone hexacetonide |
ChEMBL ID
|
CHEMBL1200878 |
Indication
|
adrenal insufficiency, allergic rhinitis perennial, ankylosing spondylitis, atopic dermatitis, berylliosis, bronchial spasm, dermatitis herpetiformis, erythema multiforme, facial dermatoses, foot dermatoses, hand dermatoses, hemolytic anemia, hypercalcemia, inflammation, leg dermatoses, multiple sclerosis, nephrotic syndrome, pemphigus, pulmonary tuberculosis, rheumatic diseases, scalp dermatoses, serum sickness, synovitis, systemic lupus erythematosus, thyroiditis, ulcerative colitis, uveitis |
Drug Class
|
Steroids (not prednisolone derivatives); topical steroids (acetal derivatives) |
Image (chem structure or protein)